Equipoise vs Deca-Durabolin: complete comparison (boldenone vs nandrolone)
| Critère | boldenone | nandrolone |
|---|---|---|
| Anabolic/androgenic ratio | 100:50 | 125:37 |
| Half-life | ~14 d (undecylenate) | ~6 d + 2-3 wk release |
| Aromatization | Weak | Very weak |
| Progestogenic effect | No | Yes (moderate) |
| HPG axis suppression | Moderate | Strong and prolonged |
| Typical dose | 400-600 mg/week | 300-400 mg/week |
| Detection (doping) | ~5 months | ~18 months |
| Effect on libido | Neutral to positive | Often negative (deca-dick) |
Quand choisir boldenone
Equipoise (boldenone undecylenate, EQ) is one of the most tolerable injectable AAS on long cycle. Soma 2007 (PK study in horse, data extrapolable to humans) established its pharmacokinetics: half-life of about 14 days thanks to the undecylenate ester (the longest commercially available), allowing stable weekly injection and very smooth serum profile. Favorable hormonal profile (Saartok 1984, Kicman 2008): weak aromatization (~50% of testosterone), no notable progestogenic effect, moderate HPG suppression. Choose it for: (1) long cycles 14-20 weeks where hormonal stability matters, (2) quality cut with marked vascularity (sought effect by bodybuilders in pre-contest), (3) increased appetite for users who struggle to eat in caloric surplus, (4) addition to a testosterone base for slow but durable gains, (5) 'clean' bulking cycle with little water retention. Drawbacks to anticipate (Pope 2014): degraded lipid profile (HDL crash), sometimes important hematocrit elevation (marked erythropoietic effect via renal EPO stimulation), very slow visible gains (little difference at W4-W6, apparent effect at W10+) — which can discourage impatient users, and ~5 month doping detectability (hydroxylated metabolite). Typical dose 400-600 mg/week in 1 weekly injection (kinetics allow low frequency).
Quand choisir nandrolone
Nandrolone decanoate (Deca-Durabolin) is the historical mass AAS, classic of slow and heavy bulking. Minto 1997 established its precise pharmacokinetics: effective half-life ~6 days with extended release from IM oil depot over 2-3 weeks. Choose it for: (1) pure mass gain with joint lubrication (sought effect in heavy bulk with elevated loads stressing tendons), (2) 12-16 week cycles combined with a testosterone base, (3) users who tolerate testo-alone water retention poorly, (4) athletes seeking sustained strength gains on long cycle. High anabolic profile (ratio 125:37, Saartok 1984) with low relative androgenicity — little acne, little hair loss compared to trenbolone or dianabol. But nandrolone-specific profile to anticipate (Pope 2014, Endocrine Society): severe and prolonged HPG axis suppression, progestogenic activity that can induce gynecomastia without aromatization (cabergoline 0.25 mg 2× per week sometimes needed if prolactin > 25 ng/mL), prolonged post-cycle serum persistence (~3 weeks after last injection), 19-norandrosterone metabolite detectable up to 18 months in anti-doping control. 'Deca-dick' effect: erectile dysfunction during and after the cycle if testosterone base is insufficient. Always combined with testosterone ≥ 200 mg/week, ideally 300-400 mg/week. Typical dose 300-400 mg/week of nandrolone.
Combinaison ?
Equipoise and nandrolone do not combine in common practice: despite their respective weak aromatization, stacking two compounds with marked HPG suppression and unfavorable lipid profile cumulates cardiovascular risks without net additive anabolic benefit. If you want EQ's vascularity/cut effect and nandrolone's heavy mass, structure in sequence: block 1 (W1-W10) testosterone + nandrolone for mass gain, 4-week transition with clean PCT, block 2 (W15-W25) testosterone + equipoise for cut and muscle quality. More practical: classic cycle testo 500 + Deca 400 for winter mass, then cycle testo 350 + EQ 600 for spring cut. If still combined (rare), scheme testo 400 + EQ 300 + Deca 200 over 14 weeks with mild AI (EQ aromatizes a bit, anastrozole 0.5 mg 2× per week) and preventive cabergoline (progestogenic nandrolone, 0.25 mg 2× per week). Strict monitoring: hematocrit every 4 weeks (EQ + nandrolone erythropoietic), complete lipids, prolactin, T total and E2. PCT 3-4 weeks after last injection with hCG + SERM 4-6 weeks. Sample 16-week sequential timeline if blocks chosen instead of combination: W0 baseline panel, Block 1 W1-W10 testo + deca (mass), W11 last deca injection, W14 PCT start, W22 PCT end + 4-week off, W26 next cycle eligible if recovered. Block 2 W26-W36 testo + EQ (lean/recomp), W37 last EQ injection (long ester), W40 PCT start, W48 post-PCT. The 6-month total commitment requires planning around competitions or off-season. Hematocrit warning specific to EQ: blood donation often necessary at W8 and W12 — schedule donation appointments in advance. Joint comfort window: deca lubricating effect persists 4-6 weeks post-cycle, allowing heavy training continuation during early off-phase. Sample injectable scheduling tip: combine all three esters on the same Monday/Thursday calendar to simplify rotation: testo enanthate, EQ, deca on Monday; testo enanthate alone on Thursday. Single-syringe co-administration acceptable if all three are in matching oil vehicles. Cabergoline supplies kept in reserve for any prolactin elevation signal during the deca phase.
FAQ
- Equipoise or deca for mass gain?
- Deca, for raw mass. Nandrolone produces larger net gains per mg (ratio 125:37 vs 100:50), with joint retention favorable to heavy training volume. Equipoise gives slower and drier gains, less water retention, more 'qualitative' profile. For a classic winter bulk, testo + Deca is the standard. For a cleaner bulk or lean bulk, testo + EQ. Combining both is rarely justified.
- Why does equipoise stimulate appetite?
- Imperfectly understood mechanism, but effect empirically documented in the majority of users. Hypotheses: (1) action on ghrelin or appetite hypothalamic centers, (2) increase in lean mass that elevates basal energy needs, (3) intrinsic anabolic effect requiring protein and energy substrate. It is one of the EQ choice arguments in users who struggle to reach target calories in caloric surplus. More marked effect than with testo or nandrolone alone.
- How long before nandrolone is undetectable?
- Relevant urinary metabolite: 19-norandrosterone (19-NA). For a user having done a standard deca cycle (300-400 mg/week × 12 weeks), the WADA threshold (2 ng/mL) remains exceeded for 12-18 months depending on cumulative exposure. For NPP (phenylpropionate), the window drops to 9-12 months. Equipoise is detectable ~5 months (5β-androst-1-en-3α-ol-17-one metabolite). For tested athletes, both compounds should be avoided — even out of competition.
- Do you need an AI with equipoise?
- Generally at reduced dose. Boldenone aromatizes at about 50% of testosterone, so in combo testo 400 + EQ 600, total aromatization is less than a 600 testo-alone cycle. Anastrozole 0.25-0.5 mg 2× per week as routine, titrate on estradiol at W4 and W8. With deca + testo, even less AI needed (deca ~5× less aromatization than testo per Kicman 2008). Always monitor measured E2, do not rely on symptoms alone.
- What PCT after equipoise?
- Late start due to long half-life: ~3-4 weeks after last injection. Scheme: hCG 1500 IU EOD × 10 days, then SERM (clomid 50/25/25/25 or nolvadex 40/20/20/20) × 4-6 weeks (Rahnema 2014). T total, LH, FSH panel at W8 post-PCT. Recovery is generally faster than after a prolonged deca cycle (moderate EQ suppression vs strong deca).
- Does equipoise raise hematocrit more than testosterone?
- Often yes, paradoxically. Although less potent in anabolic gains, EQ has a marked erythropoietic effect probably by renal EPO stimulation. Many users observe hematocrit > 54% under EQ 600 mg/week while staying under 52% with equivalent testo 600 mg/week. Hematocrit monitoring at W0, W6, W12 mandatory. Action required (blood donation, dose reduction) at 54%.
- Does oral equipoise exist?
- No. Boldenone has no valid commercialized oral form. Products claiming 'oral boldenone' are actually dianabol (methandrostenolone, structurally very close via its 1,2 double bond) or another 17α-alkylated renamed for marketing. Any authentic boldenone today is in injectable undecylenate form (very long 14-day kinetics) or more rarely boldenone cypionate. The underground market sometimes offers experimental esters (acetate, propionate) but their short kinetics have no advantage over other injectable short-ester AAS available elsewhere.